Cole W G, Chow C W, Bateman J F, Sillence D O
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.
J Med Genet. 1996 Nov;33(11):965-7. doi: 10.1136/jmg.33.11.965.
The features of a baby with lethal perinatal osteogenesis imperfecta (OI-II), resulting from the substitution of tryptophan 94 by cysteine in the carboxyl-terminal propeptide of pro alpha 1 (I) chains of type I procollagen, were studied. The limbs and torso were of normal length, shape, and proportion. Similarly, all bones were of relatively normal shape and the long bones showed normal metaphyseal modelling. These clinical and radiographic features were similar to those observed in another baby with OI-II resulting from a mutation of the carboxy-terminal propeptide of pro alpha 1 (I) chains but dissimilar from those reported in babies with OI-II resulting from helical mutations of type I collagen.
研究了一名患有致死性围生期成骨不全(OI-II型)婴儿的特征,该病症是由I型前胶原α1(I)链羧基末端前肽中第94位色氨酸被半胱氨酸取代所致。四肢和躯干长度、形状及比例正常。同样,所有骨骼形状相对正常,长骨表现出正常的干骺端塑形。这些临床和影像学特征与另一名因α1(I)链羧基末端前肽突变导致OI-II型的婴儿所观察到的特征相似,但与I型胶原螺旋突变导致OI-II型的婴儿所报道的特征不同。